Monday 19 October 2026
Export PFSA’s income statement to Excel — free account
PROFUSA, Inc.
PFSA Healthcare Medical Devices
PROFUSA, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $100,000.00. In the quarter to June 2026, EPS grew 98.3%, free cash flow fell 359.3% and total debt fell 89.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.93
0.14
−13.08%
Follow PFSA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 173.14% | 172.08% | 49.12% | 167.48% |
+8 more TTM periods Free account |
|
| (2,860.47%) | (2,569.79%) | (1,046.23%) | (502.86%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
157.73% | 128.99% | 193.78% | 169.40% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(366.66) | (1,133.14) | (5,369.41) | (2,704.05) | |
Free Cash Flow |
(21.27) | (19.15) | (18.26) | (11.36) | |
Capital Expenditures |
(0.94) | (0.86) | (2.01) | — | |
| Other line items | |||||
Cash ROIC |
100.05% | 83.20% | 165.17% | 103.95% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(6.03) | (7.50) | (5.44) | (3.68) | |
Operating CF/Net income |
0.47 | 0.50 | 0.45 | 0.35 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | — | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(350.52) | (1,082.07) | (4,778.82) | (2,704.05) | |
Capex per Share |
(16.14) | (51.07) | (590.59) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates